The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: Data from the CATIE schizophrenia trial sample at baseline
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
Lieberman, J. A., Stroup, T. S., McEvoy, J. P., Swartz, M. S., Rosenheck, R. A., Perkins, D. O., Keefe, R. S. E., Davis, S. M., Davis, C. E., Lebowitz, B. D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051688 · Cited by 5,892
Self-citationConsensus Development Conference on Antipsychotic Drugs and Obesity and Diabetes
Boehm, G., Racoosin, J. A., Laughren, T. P., & Katz, R. (2004) · Diabetes Care · doi:10.2337/diacare.27.8.2088-a · Cited by 1,204
McEvoy, J. P., Meyer, J. M., Goff, D. C., Nasrallah, H. A., Davis, S. M., Sullivan, L., Meltzer, H. Y., Hsiao, J., Scott Stroup, T., & Lieberman, J. A. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.07.014 · Cited by 1,140
Self-citationSchizophrenia and increased risks of cardiovascular disease
Hennekens, C. H., Hennekens, A. R., Hollar, D., & Casey, D. E. (2005) · American Heart Journal · doi:10.1016/j.ahj.2005.02.007 · Cited by 1,070
Excess mortality of schizophrenia: A meta-analysis
Brown, S. (1997) · British Journal of Psychiatry · doi:10.1192/bjp.171.6.502 · Cited by 869
Physical Health Monitoring of Patients With Schizophrenia
Marder, S. R., Essock, S. M., Miller, A. L., Buchanan, R. W., Casey, D. E., Davis, J. M., Kane, J. M., Lieberman, J. A., Schooler, N. R., Covell, N., et al. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.8.1334 · Cited by 812
Self-citationMortality and causes of death in schizophrenia in Stockholm County, Sweden
Ösby, U., Correia, N., Brandt, L., Ekbom, A., & Sparén, P. (2000) · Schizophrenia Research · doi:10.1016/s0920-9964(99)00191-7 · Cited by 679
Stroup, T. S., McEvoy, J. P., Swartz, M. S., Byerly, M. J., Glick, I. D., Canive, J. M., McGee, M. F., Simpson, G. M., Stevens, M. C., & Lieberman, J. A. (2003) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a006986 · Cited by 636
Self-citationThe Treatment of Unrelated Disorders in Patients with Chronic Medical Diseases
Redelmeier, D. A., Tan, S. H., & Booth, G. L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199805213382106 · Cited by 635
Prevalence and Correlates of Diabetes in National Schizophrenia Samples
Dixon, L., Weiden, P., Delahanty, J., Goldberg, R., Postrado, L., Lucksted, A., & Lehman, A. (2000) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033504 · Cited by 569
Mental Disorders and Use of Cardiovascular Procedures After Myocardial Infarction
Druss, B. G. (2000) · JAMA · doi:10.1001/jama.283.4.506 · Cited by 534
Goff, D. C., Sullivan, L. M., McEvoy, J. P., Meyer, J. M., Nasrallah, H. A., Daumit, G. L., Lamberti, S., D'Agostino, R. B., Stroup, T. S., Davis, S., et al. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.08.010 · Cited by 528
Self-citationQuality of Medical Care and Excess Mortality in Older Patients With Mental Disorders
Druss, B. G., Bradford, W. D., Rosenheck, R. A., Radford, M. J., & Krumholz, H. M. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.6.565 · Cited by 489
Mortality and Causes of Death in First Admitted Schizophrenic Patients
Mortensen, P. B., & Juel, K. (1993) · British Journal of Psychiatry · doi:10.1192/bjp.163.2.183 · Cited by 412
The effects of antipsychotic therapy on serum lipids: a comprehensive review
Meyer, J. M., & Koro, C. E. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2004.01.014 · Cited by 407
Self-citation(2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0219 · Cited by 383
Mortality in a Cohort of Patients with Schizophrenia: A Record Linkage Study*
Newman, S. C., & Bland, R. C. (1991) · The Canadian Journal of Psychiatry · doi:10.1177/070674379103600401 · Cited by 371
The Association of Medical Comorbidity in Schizophrenia with Poor Physical and Mental Health
DIXON, L., POSTRADO, L., DELAHANTY, J., FISCHER, P. J., & LEHMAN, A. (1999) · The Journal of Nervous & Mental Disease · doi:10.1097/00005053-199908000-00006 · Cited by 360
Schizophrenia: A Life-shortening Disease
Allebeck, P. (1989) · Schizophrenia Bulletin · doi:10.1093/schbul/15.1.81 · Cited by 335
Sokal, J., Messias, E., Dickerson, F. B., Kreyenbuhl, J., Brown, C. H., Goldberg, R. W., & Dixon, L. B. (2004) · Journal of Nervous & Mental Disease · doi:10.1097/01.nmd.0000130135.78017.96 · Cited by 320
Jones, D. R., Macias, C., Barreira, P. J., Fisher, W. H., Hargreaves, W. A., & Harding, C. M. (2004) · Psychiatric Services · doi:10.1176/appi.ps.55.11.1250 · Cited by 317
Cohn, T., Prud'homme, D., Streiner, D., Kameh, H., & Remington, G. (2004) · The Canadian Journal of Psychiatry · doi:10.1177/070674370404901106 · Cited by 254
Cardiovascular Risk Factors for People with Mental Illness
Davidson, S., Judd, F., Jolley, D., Hocking, B., Thompson, S., & Hyland, B. (2001) · Australian & New Zealand Journal of Psychiatry · doi:10.1046/j.1440-1614.2001.00877.x · Cited by 249
Prevalence of Diabetes and Impaired Fasting Glucose in Adults—United States, 1999-2000
(2003) · JAMA · doi:10.1001/jama.290.13.1702 · Cited by 225
Winer, N., & Sowers, J. R. (2004) · The Journal of Clinical Pharmacology · doi:10.1177/0091270004263017 · Cited by 223
Time trends in schizophrenia mortality in Stockholm county, Sweden: cohort study
Osby, U. (2000) · BMJ · doi:10.1136/bmj.321.7259.483 · Cited by 220
Serious Cardiovascular Events and Mortality Among Patients with Schizophrenia
Enger, C., Weatherby, L., Reynolds, R. F., Glasser, D. B., & Walker, A. M. (2004) · Journal of Nervous & Mental Disease · doi:10.1097/01.nmd.0000105996.62105.07 · Cited by 215
Prevalence of diabetes and impaired glucose tolerance in patients with schizophrenia
Bushe, C., & Holt, R. (2004) · British Journal of Psychiatry · doi:10.1192/bjp.184.47.s67 · Cited by 212
Mental Disorders and Quality of Diabetes Care in the Veterans Health Administration
Desai, M. M., Rosenheck, R. A., Druss, B. G., & Perlin, J. B. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.9.1584 · Cited by 209
Mental Disorders and Access to Medical Care in the United States
Druss, B. G., & Rosenheck, R. A. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.12.1775 · Cited by 209
Barriers to Primary Medical Care Among Patients at a Community Mental Health Center
Levinson Miller, C., Druss, B. G., Dombrowski, E. A., & Rosenheck, R. A. (2003) · Psychiatric Services · doi:10.1176/appi.ps.54.8.1158 · Cited by 209
Cardiovascular Disease in Patients With Schizophrenia in Saskatchewan, Canada
Curkendall, S. M., Mo, J., Glasser, D. B., Stang, M. R., & Jones, J. K. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0519 · Cited by 200
Use of General Medical Services by VA Patients With Psychiatric Disorders
Cradock-O'Leary, J., Young, A. S., Yano, E. M., Wang, M., & Lee, M. L. (2002) · Psychiatric Services · doi:10.1176/appi.ps.53.7.874 · Cited by 197
Atypical antipsychotics and glucose dysregulation: a systematic review
Jin, H., Meyer, J. M., & Jeste, D. V. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2004.03.024 · Cited by 195
Self-citationMortality and causes of death in schizophrenic patients in Denmark
Mortensen, P. B., & Juel, K. (1990) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1990.tb05466.x · Cited by 138
Newcomer, J. W., Nasrallah, H. A., & Loebel, A. D. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000142281.85207.d5 · Cited by 132
Self-citationA Comparison of Type 2 Diabetes Outcomes Among Persons With and Without Severe Mental Illnesses
Dixon, L. B., Kreyenbuhl, J. A., Dickerson, F., Donner, T. W., Brown, C. H., Wolheiter, K., Postrado, L. T., Goldberg, R. W., Fang, L., Marano, C. M., et al. (2004) · Psychiatric Services · doi:10.1176/appi.ps.55.8.892 · Cited by 116
Use and Monitoring of "Statin" Lipid-Lowering Drugs Compared With Guidelines
Abookire, S. A., Karson, A. S., Fiskio, J. M., & Bates, D. W. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.1.53 · Cited by 115
Troisi, R. J., Cowie, C. C., & Harris, M. I. (2000) · JAMA · doi:10.1001/jama.284.24.3157 · Cited by 108
Do guidelines for severe mental illness promote physical health and well-being?
Citrome, L., & Yeomans, D. (2005) · Journal of Psychopharmacology · doi:10.1177/0269881105059505 · Cited by 103
Clinicians' recognition of the metabolic adverse effects of antipsychotic medications
Buckley, P. F., Miller, D. D., SINGER, B., ARENA, J., & Stirewalt, E. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.04.010 · Cited by 102
Use of Medical Services by Veterans With Mental Disorders
Druss, B. G., & Rosenheck, R. A. (1997) · Psychosomatics · doi:10.1016/s0033-3182(97)71422-1 · Cited by 92
Medical Illness and Schizophrenia
Meyer, J. M., & Nasrallah, H. A. (2003) · Medical Entomology and Zoology · Cited by 85
Self-citationMortality Among Patients With Schizophrenia
Simpson, J. C., & Tsuang, M. T. (1996) · Schizophrenia Bulletin · doi:10.1093/schbul/22.3.485 · Cited by 77
Lamberti, J. S., Crilly, J. F., Maharaj, K., Olson, D. P., Wiener, K., Dvorin, S., Costea, G. O., Bushey, M. P., & Dietz, M. B. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0517 · Cited by 74
The Urgent Need to Improve Hypertension Care
Trilling, J. S., & Froom, J. (2000) · Archives of Family Medicine · doi:10.1001/archfami.9.9.794 · Cited by 73
Undertreatment and overtreatment with statins: the Oslo Health Study 2000–2001
Tonstad, S., Rosvold, E. O., Furu, K., & Skurtveit, S. O. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01315.x · Cited by 72
Medical Illness and Schizophrenia
Cascella, N. G. (2004) · The Journal of Nervous and Mental Disease · doi:10.1097/01.nmd.0000144964.83457.32 · Cited by 59
The mental health/primary care interface in the United States: history, structure, and context
Druss, B. G. (2002) · General Hospital Psychiatry · doi:10.1016/s0163-8343(02)00170-6 · Cited by 42
Desai, M. M., Rosenheck, R. A., Druss, B. G., & Perlin, J. B. (2002) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2002.10660.x · Cited by 40
The undertreatment of LDL-cholesterol: addressing the challenge
Pearson, T. A. (2000) · International Journal of Cardiology · doi:10.1016/s0167-5273(99)00108-4 · Cited by 39
Community-Based screening for cardiovascular disease and diabetes using HbA1c
Grant, T., Soriano, Y., Marantz, P. R., Nelson, I., Williams, E., Ramirez, D. C., Burg, J., & Nordin, C. (2004) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2003.12.015 · Cited by 36
Pharmacoeconomic Burden of Undertreating Hypertension
Esposti, L. D., & Valpiani, G. (2004) · PharmacoEconomics · doi:10.2165/00019053-200422140-00002 · Cited by 34
THE HUMAN AND ECONOMIC COSTS OF UNDERTREATMENT WITH STATINS
Durrington, P. N. (2002) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2002.tb11276.x · Cited by 23
Undertreatment of Hypertension: A Dozen Reasons
Gupta, K., & Gupta, S. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.19.2246 · Cited by 21
Use of Psychiatric and Medical Health Care by Veterans With Severe Mental Illness
Bosworth, H. B., Calhoun, P. S., Stechuchak, K. M., & Butterfield, M. I. (2004) · Psychiatric Services · doi:10.1176/appi.ps.55.6.708 · Cited by 9
Cited by
DE HERT, M., CORRELL, C. U., BOBES, J., CETKOVICH‐BAKMAS, M., COHEN, D., ASAI, I., DETRAUX, J., GAUTAM, S., MÖLLER, H., NDETEI, D. M., et al. (2011) · World Psychiatry · doi:10.1002/j.2051-5545.2011.tb00014.x · Cited by 2,488
Metabolic and cardiovascular adverse effects associated with antipsychotic drugs.
De Hert, M., Detraux, J., van Winkel, R., Yu, W., & Correll, C. U. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.156 · Cited by 1,145
Schizophrenia, “just the facts” 4. Clinical features and conceptualization
Tandon, R., Nasrallah, H. A., & Keshavan, M. S. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.03.005 · Cited by 1,027
Self-citationDe Hert, M., Dekker, J. M., Wood, D., Kahl, K. G., Holt, R. I. G., & Möller, H.-J. (2009) · European Psychiatry · doi:10.1016/j.eurpsy.2009.01.005 · Cited by 951
“Low rates of treatment for hypertension, dyslipidaemia and diabetes have been reported in schizophrenia patients [96].”
BackgroundDE HERT, M., COHEN, D., BOBES, J., CETKOVICH‐BAKMAS, M., LEUCHT, S., NDETEI, D. M., NEWCOMER, J. W., UWAKWE, R., ASAI, I., MÖLLER, H., et al. (2011) · World Psychiatry · doi:10.1002/j.2051-5545.2011.tb00036.x · Cited by 870
Metadata
- Authors
- Nasrallah, H. A., Meyer, J. M., Goff, D. C., McEvoy, J. P., Davis, S. M., Stroup, T. S., & Lieberman, J. A.
- Venue
- Schizophrenia Research
- Publisher
- Elsevier BV
- Published
- 2006-09
- Volume
- 86
- Issue
- 1-3
- Pages
- 15-22
- ISSN
- 0920-9964 (ISSN-L)
- OpenAlex
- W2163093342
- Cited by
- 556
- References
- 56
- FWCI
- 17.63
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.